Article

Claire E. Dearden, MD, Highlights the Pharmacotherapeutic Strategies for the Management of B- and T-cell PLL

Claire E. Dearden, MD, Consultant Hematologist, Head of CLL Clinic, Royal Marsden Hospital, London, UK, highlights the pharmacotherapeutic strategies for the management of B- and T-cell PLL, noting the clinical outcomes associated with the diseases, and briefly touches on the future of PLL therapy.

Claire E. Dearden, MD, Consultant Hematologist, Head of CLL Clinic, Royal Marsden Hospital, London, UK, highlights the pharmacotherapeutic strategies for the management of B- and T-cell PLL, noting the clinical outcomes associated with the diseases, and briefly touches on the future of PLL therapy.

This video was taken on Saturday, December 8, at the American Society of Hematology's 54th Annual Meeting in Atlanta, GA.

Related Videos
Ibrahim Aldoss, MD, associate professor, City of Hope
James Chalmers, MD
Vincent Picozzi, MD, medical oncologist and director of the pancreaticobiliary program, Virginia Mason
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
 Priscilla Tsondai, MD, MPH, International AIDS Society/CIPHER
ASCO Preview 2025
James Chalmers, MD
Nini Wu, MD, Navista
ATS 2025
Bridgette J. Picou, LVN, ACLPN, The Well Project
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo